Fidelity Investments’s Cyclerion Therapeutics CYCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.8K Sell
4,740
-200
-4% -$582 ﹤0.01% 4424
2025
Q1
$12.2K Buy
4,940
+200
+4% +$494 ﹤0.01% 4434
2024
Q4
$15.3K Sell
4,740
-152,896
-97% -$492K ﹤0.01% 4292
2024
Q3
$407K Sell
157,636
-3,783
-2% -$9.76K ﹤0.01% 2934
2024
Q2
$368K Sell
161,419
-908
-0.6% -$2.07K ﹤0.01% 2833
2024
Q1
$519K Sell
162,327
-522
-0.3% -$1.67K ﹤0.01% 2704
2023
Q4
$546K Sell
162,849
-1,700
-1% -$5.7K ﹤0.01% 2660
2023
Q3
$559K Sell
164,549
-400
-0.2% -$1.36K ﹤0.01% 2601
2023
Q2
$678K Sell
164,949
-4,569
-3% -$18.8K ﹤0.01% 2569
2023
Q1
$1.47M Sell
169,518
-1,530
-0.9% -$13.3K ﹤0.01% 2441
2022
Q4
$2.24M Buy
171,048
+355
+0.2% +$4.66K ﹤0.01% 2345
2022
Q3
$2.94M Buy
170,693
+43,807
+35% +$754K ﹤0.01% 2321
2022
Q2
$1.39M Sell
126,886
-3,865
-3% -$42.4K ﹤0.01% 2594
2022
Q1
$2.9M Sell
130,751
-120
-0.1% -$2.66K ﹤0.01% 2503
2021
Q4
$4.5M Sell
130,871
-1,560
-1% -$53.7K ﹤0.01% 2395
2021
Q3
$8.13M Sell
132,431
-1,310
-1% -$80.4K ﹤0.01% 2196
2021
Q2
$10.4M Sell
133,741
-2,575
-2% -$201K ﹤0.01% 2089
2021
Q1
$7.61M Buy
136,316
+330
+0.2% +$18.4K ﹤0.01% 2139
2020
Q4
$8.32M Sell
135,986
-850
-0.6% -$52K ﹤0.01% 2027
2020
Q3
$16.6M Sell
136,836
-370
-0.3% -$45K ﹤0.01% 1638
2020
Q2
$16.2M Sell
137,206
-1
-0% -$118 ﹤0.01% 1632
2020
Q1
$7.27M Buy
137,207
+10,633
+8% +$564K ﹤0.01% 1801
2019
Q4
$6.89M Sell
126,574
-10,265
-8% -$558K ﹤0.01% 1971
2019
Q3
$33.2M Sell
136,839
-23
-0% -$5.58K ﹤0.01% 1363
2019
Q2
$31.3M Buy
+136,862
New +$31.3M ﹤0.01% 1428